Catalyst Wire Dossier Catalyst Wire Dossier

Atriance

nelarabine · Sandoz Pharmaceuticals d.d.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atriance, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: EMA Authorised: Atriance (nelarabine) — Sandoz Pharmaceuticals d.d.

See pricing